Enhanced distribution and anti-tumor activity of ergosta-4,6,8(14),22- tetraen-3-one by polyethylene glycol liposomalization

Journal of Nanoscience and Nanotechnology

Volumn 13, Issue 2, 2013, Pages 1435-1439

  Sun, Yang ^a   Ji, Zhen ^a   Zhao, Yingyong ^a   Liang, Xuhua ^a   Hu, Xiaoyun ^a   Fan, Jun ^a  

^a NORTHWEST UNIVERSITY   (China)

Author keywords

Enhanced permeability and retention (EPR); Ergosta 4,6,8(14),22 tetraen 3 one; In vitro cytotoxicity; Liposome; PEG

Indexed keywords

ENHANCED PERMEABILITY AND RETENTIONS; ERGOSTA-4,6,8(14),22-TETRAEN-3-ONE; IN-VITRO; INTRAVENOUS INJECTIONS; PHARMACOKINETIC ANALYSIS; PHARMACOLOGICAL ACTIVITY; POLYETHYLENE GLYCOL (PEG); RETICULOENDOTHELIAL SYSTEMS;

CARDIOVASCULAR SYSTEM; CHEMOTHERAPY; LIPOSOMES; PHARMACOKINETICS; RATS; TUMORS;

POLYETHYLENE GLYCOLS;

ANTINEOPLASTIC AGENT; CHOLEST 4 EN 3 ONE; DRUG CARRIER; ERGOSTA 4,6,8(14),22 TETRAEN 3 ONE; ERGOSTA-4,6,8(14),22-TETRAEN-3-ONE; LIPOSOME; MACROGOL DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG SCREENING; FEMALE; HUMAN; MOUSE; NUDE MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHOLESTENONES; DRUG CARRIERS; FEMALE; HUMANS; LIPOSOMES; MICE; MICE, NUDE; POLYETHYLENE GLYCOLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MLCS; MLOWN;

EID: 84876261903     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2013.6009     Document Type: Conference Paper

References (20)

1. Y. Y. Zhao, X. Chao, Y. M. Zhang, R. C. Lin, and W. J. Sun, Planta Med. 76, 1 (2010).
2. Y. Y. Zhao, R. M. Xie, X. Chao, Y. M. Zhang, R. C. Lin, and W. J. Sun, J. Ethnopharmacol. 126, 184 (2009).
3. Y. Y. Zhao, X. L. Cheng, P. Zhang, Y. Zhao, R. C. Lin, and W. J. Sun, Chin. Pharm. Anal. 29, 1579 (2009).
4. Y. Y. Zhao, X. L. Cheng, Y. M. Zhang, Y. Zhao, R. C. Lin, and W. J. Sun, Biomed. Chromatogr. 24, 222 (2009).
5. Y. Y. Zhao, Y. Zhao, Y. M. Zhang, R. C. Lin, and W. J. Sun, Pharmazie 64, 366 (2009).
6. Y. Y. Zhao, X. Y. Qin, Y. M. Zhang, R. C. Lin, W. J. Sun, and X. Y. Li, Biomed. Chromatogr. 24, 1120 (2010).
7. Y. Y. Zhao, X. Y. Qin, X. L. Chen, X. Y. Liu, R. C. Lin, Y. M. Zhang, X. Y. Li, X. L. Sun, and W. J. Sun, Anal. Chim. Acta 675, 199 (2010).
8. Y. Yoshizawa, Y. Kono, K. Ogawara, T. Kimura, and K. Higaki, Int. J. Pharm. 412, 132 (2011).
9. K. Kawano, E. Onose, Y. Hattori, and Y. Maitani, Mol. Pharm. 6, 98 (2008).
10. M. Saad, O. B. Garbuzenko, E. Ber, P. Chandna, J. J. Khandare, V. P. Pozharov, and T. J. Minko, J. Control Release 130, 107 (2008).
11. Y. B. Patil, U. S. Toti, A. Khdair, L. Ma, and J. Panyam, Biomaterials 30, 859 (2009).
12. X. B. Xiong, Y. Huang, W. L. Lu, X. Zhang, H. Zhang, T. Nagai, and Q. Zhang. J. Pharm. Sci. 94, 1782 (2005).
13. Y. Y. Zhao, X. L. Cheng, R. Liu, C. C. Ho, F. Wei, S. H. Yan, R. C. Lin, Y. M. Zhang, and W. J. Sun, J. Chromatogr. B 879, 1945 (2011).
14. A. S. A. Lila, Y. Doi, K. Nakamura, T. Ishida, and H. Kiwada, J. Control Release 142, 167 (2010).
15. Y. Y. Zhao, X. L. Cheng, Y. M. Zhang, X. Chao, Y. Zhao, R. C. Lin, and W. J. Sun, J. Chromatogr. B 878, 29 (2010).
16. Y. Y. Zhao, X. Chao, Y. M. Zhang, R. C. Lin, and W. J. Sun, Planta Med. 76, 1 (2010).
17. J. Yokoe, S. Sakuragi, K. Yamamoto, T. Teragaki, K. Ogawara, K. Higaki, N. Katayama, T. Kai, M. Sato, and T. Kimura, Int. J. Pharm. 353, 28 (2008).
18. S. M. Moghimi and J. Szebeni, Pro. Lipid. Res. 42, 463 (2003).
19. M. S. Muthu, S. A. Kulkarni, J. Q. Xiong, and S. S. Feng, Int. J. Pharm. 421, 332 (2011).
20. K. Maruyama, Adv. Drug Deliv. Rev. 63, 161 (2011).